PROLIV: MOOD Study Results Leading to Home Based Neuromodulation Therapy for Patients Who Do Not Respond to Antidepressants
Time: 4:00 pm
day: Conference Day 1 PM
Details:
- FDA Breakthrough Designation
- First home based Neuromodulation Wearable Therapy to successfully treat severe and treatment resistant MDD
